CA Stock MarketDetailed Quotes

CRDL Cardiol Therapeutics Inc

Watchlist
  • 2.280
  • -0.240-9.52%
15min DelayTrading Nov 19 15:32 ET
186.06MMarket Cap-4222P/E (TTM)

Cardiol Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
84.70%14.14M
22.59%7.74M
7.95%8.41M
-27.94%29.79M
-11.72%8.03M
-42.09%7.66M
-31.60%6.31M
-20.46%7.79M
6.69%41.34M
-30.56%9.1M
Selling and administrative expenses
104.56%10.39M
77.47%5.03M
38.93%5.08M
-30.45%15.56M
14.71%3.99M
-37.53%5.08M
-41.24%2.84M
-38.42%3.66M
-19.73%22.37M
-63.67%3.48M
-General and administrative expense
104.56%10.39M
77.47%5.03M
38.93%5.08M
-30.45%15.56M
14.71%3.99M
-37.53%5.08M
-41.24%2.84M
-38.42%3.66M
-19.73%22.37M
-63.67%3.48M
Research and development costs
45.56%3.75M
-22.12%2.71M
-19.50%3.32M
-24.99%14.22M
-28.08%4.04M
-49.37%2.58M
-21.05%3.48M
7.28%4.13M
74.44%18.96M
59.25%5.62M
Operating profit
-84.70%-14.14M
-22.59%-7.74M
-7.95%-8.41M
27.94%-29.79M
11.72%-8.03M
42.09%-7.66M
31.60%-6.31M
20.46%-7.79M
-6.91%-41.34M
30.56%-9.1M
Net non-operating interest income (expenses)
-60.84%201.86K
-41.86%307.41K
-30.89%377.29K
64.71%2.04M
-23.32%448.3K
32.41%515.54K
176.32%528.7K
654.97%545.93K
1,067.57%1.24M
2,005.55%584.65K
Non-operating interest income
-60.84%201.86K
-41.86%307.41K
-30.89%377.29K
64.71%2.04M
-23.32%448.3K
32.41%515.54K
176.32%528.7K
654.97%545.93K
1,067.57%1.24M
2,005.55%584.65K
Other net income (expenses)
-0.01%1.21M
150.01%843.06K
-863.19%-1.15M
-104.16%-381.25K
-105.68%-56.49K
-75.09%1.21M
-166.07%-1.69M
-80.20%150.87K
32.47%9.17M
-85.39%995.35K
Gain on sale of security
14.11%1.21M
150.01%843.06K
-881.89%-1.18M
-105.90%-530.99K
-105.68%-56.49K
-77.41%1.06M
-166.07%-1.69M
-80.20%150.87K
32.24%9M
-85.35%995.35K
Other non-operating income (expenses)
----
----
--28.22K
-8.94%149.74K
--0
-8.94%149.74K
----
----
46.52%164.44K
--0
Income before tax
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Income tax
Earnings from equity interest net of tax
Net income
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Net income continuous operations
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Noncontrolling interests
Net income attributable to the company
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Diluted earnings per share
-100.00%-0.18
16.67%-0.1
-27.27%-0.14
10.20%-0.44
-9.09%-0.12
30.77%-0.09
-20.00%-0.12
21.43%-0.11
32.88%-0.49
-37.50%-0.11
Basic earnings per share
-100.00%-0.18
16.67%-0.1
-27.27%-0.14
10.20%-0.44
-9.09%-0.12
30.77%-0.09
-20.00%-0.12
21.43%-0.11
32.88%-0.49
-37.50%-0.11
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 84.70%14.14M22.59%7.74M7.95%8.41M-27.94%29.79M-11.72%8.03M-42.09%7.66M-31.60%6.31M-20.46%7.79M6.69%41.34M-30.56%9.1M
Selling and administrative expenses 104.56%10.39M77.47%5.03M38.93%5.08M-30.45%15.56M14.71%3.99M-37.53%5.08M-41.24%2.84M-38.42%3.66M-19.73%22.37M-63.67%3.48M
-General and administrative expense 104.56%10.39M77.47%5.03M38.93%5.08M-30.45%15.56M14.71%3.99M-37.53%5.08M-41.24%2.84M-38.42%3.66M-19.73%22.37M-63.67%3.48M
Research and development costs 45.56%3.75M-22.12%2.71M-19.50%3.32M-24.99%14.22M-28.08%4.04M-49.37%2.58M-21.05%3.48M7.28%4.13M74.44%18.96M59.25%5.62M
Operating profit -84.70%-14.14M-22.59%-7.74M-7.95%-8.41M27.94%-29.79M11.72%-8.03M42.09%-7.66M31.60%-6.31M20.46%-7.79M-6.91%-41.34M30.56%-9.1M
Net non-operating interest income (expenses) -60.84%201.86K-41.86%307.41K-30.89%377.29K64.71%2.04M-23.32%448.3K32.41%515.54K176.32%528.7K654.97%545.93K1,067.57%1.24M2,005.55%584.65K
Non-operating interest income -60.84%201.86K-41.86%307.41K-30.89%377.29K64.71%2.04M-23.32%448.3K32.41%515.54K176.32%528.7K654.97%545.93K1,067.57%1.24M2,005.55%584.65K
Other net income (expenses) -0.01%1.21M150.01%843.06K-863.19%-1.15M-104.16%-381.25K-105.68%-56.49K-75.09%1.21M-166.07%-1.69M-80.20%150.87K32.47%9.17M-85.39%995.35K
Gain on sale of security 14.11%1.21M150.01%843.06K-881.89%-1.18M-105.90%-530.99K-105.68%-56.49K-77.41%1.06M-166.07%-1.69M-80.20%150.87K32.24%9M-85.35%995.35K
Other non-operating income (expenses) ----------28.22K-8.94%149.74K--0-8.94%149.74K--------46.52%164.44K--0
Income before tax -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Income tax
Earnings from equity interest net of tax
Net income -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Net income continuous operations -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Noncontrolling interests
Net income attributable to the company -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Diluted earnings per share -100.00%-0.1816.67%-0.1-27.27%-0.1410.20%-0.44-9.09%-0.1230.77%-0.09-20.00%-0.1221.43%-0.1132.88%-0.49-37.50%-0.11
Basic earnings per share -100.00%-0.1816.67%-0.1-27.27%-0.1410.20%-0.44-9.09%-0.1230.77%-0.09-20.00%-0.1221.43%-0.1132.88%-0.49-37.50%-0.11
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data